- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Zhongyuan Xu
Total 1075 results
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruitingCoronary Artery Disease | Angina, StableChina
-
Shanghai Zhongshan HospitalNot yet recruitingRadiation Therapy | Spinal Bone Metastases
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalNot yet recruitingPosto Perative Hepatocellular Carcinoma
-
Shanghai Zhongshan HospitalRecruitingCOVID-19 | Respiratory Distress Syndrome, AdultChina
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalNot yet recruitingEsophageal Squamous Cell CarcinomaChina
-
Shanghai Zhongshan HospitalRecruitingCoronary Artery DiseaseChina
-
Shanghai Zhongshan HospitalRecruitingReconstruction | Proximal Gastric AdenocarcinomaChina
-
Shanghai Zhongshan HospitalNot yet recruitingBlood Purification | Dual-cannula | Vena Cava Disconnection
-
Shanghai Zhongshan HospitalRecruitingCOVID-19 | Hydrogen-oxygen Gas | AMS-H-03China
-
Shanghai Zhongshan HospitalRecruitingThymic Epithelial TumorChina
-
Shanghai Zhongshan HospitalNot yet recruitingPostoperative Delirium | Cardiac Surgery
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingHeart Failure, Systolic | Sudden Cardiac DeathChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingCardiovascular Diseases | Type 2 Diabetes | Cardiac Perfusion DefectChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalRecruitingSleep Quality | Circadian Rhythm | Intensive Care Unit DeliriumChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalRecruitingColorectal Neoplasms MalignantChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingA Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCCHepatocellular Carcinoma | DonafenibChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruitingHepatocellular Carcinoma Stage III
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingPostoperative Nausea and Vomiting | Prediction Model | Hepatobiliary SurgeryChina
-
Shanghai Zhongshan HospitalRecruitingPacemaker DependenceChina
-
Shanghai Zhongshan HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shanghai Zhongshan HospitalRecruitingSurgery | Resectable Pancreatic Cancer | Adjuvant ChemoradiotherapyChina
-
Shanghai Zhongshan HospitalRecruitingARDS | Prone Position | Electrical Impedance TomographyChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingCholangiocarcinoma, Intrahepatic | PD-L1 | CTLA4China
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalRecruitingCardiovascular Diseases | Diabetes Mellitus | Complication DiabeticChina
-
Shanghai Zhongshan HospitalRecruitingHepatocellular Carcinoma | Immunotherapy | Molecular Targeted TherapyChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalNot yet recruitingStomach Neoplasms | Circulating Tumor DNA
-
Shanghai Zhongshan HospitalRecruitingTakayasu Arteritis | Methotrexate | Inhibition | TreatmentChina
-
Shanghai Zhongshan HospitalRecruitingOesophageal Squamous Cell CarcinomaChina